Cas:610794-15-5 4-Bromo-5-methyl-1H-indole manufacturer & supplier

Chemical Name:4-Bromo-5-methyl-1H-indole

CAS.NO:610794-15-5

Synonyms:4-Bromo-5-methyl-1H-indole;1H-Indole, 4-bromo-5-methyl-;5-methyl-4-bromoindole;4-Bromo-5-methylindole

Molecular Formula:C₉H₈BrN

Molecular Weight:210.070

HS Code:2933990090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:328.5±22.0 °C at 760 mmHg

Density:1.6±0.1 g/cm3

Index of Refraction:1.685

PSA:15.79000

Exact Mass:208.984009

LogP:3.37

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Bromo-5-methyl-1H-indole chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Bromo-5-methylindole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Bromo-5-methylindole Use and application,4-Bromo-5-methyl-1H-indole technical grade,usp/ep/jp grade.

Related News: High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies. 4-Bromo-5-methyl-1H-indole manufacturer In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 4-Bromo-5-methyl-1H-indole supplier In addition, the FDA approval ignored the recommendation of its outside advisors, who said Biogen did not provide enough evidence of clinical benefit. Three of the advisory panel’s members have resigned in protest since the FDA decision was announced on Monday. 4-Bromo-5-methyl-1H-indole vendor It’s a disturbing set of events, scientifically, clinically, politically, Karlawish said. 4-Bromo-5-methyl-1H-indole factory High-barrier generic drugs: Usually for the production of drugs whose patents have just expired or are about to expire, the market is only competed by original research and a few generic drug companies.